Impact of a Hematologic Malignancy Diagnosis and Treatment on Patients and Their Family Caregivers

Hematologic malignancies (HMs) are a heterogeneous group of cancers that affect the blood, bone marrow, and lymph nodes. Many HMs are aggressive cancers requiring prompt treatment for control and survival. Patients with HM commonly require sudden and protracted hospital stays for the diagnosis and treatment of their disease. These hospitalizations frequently last for at least three to four weeks with ongoing monthly admissions for several days at a time thereafter.